GF
MRNS

Gabelli Funds’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Gabelli Funds’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,750
Closed -$69K – 1153
2020
Q2 		$69K Hold
6,750
– – ﹤0.01% 1028
2020
Q1 		$55K Hold
6,750
– – ﹤0.01% 1032
2019
Q4 		$58K Hold
6,750
– – ﹤0.01% 1069
2019
Q3 		$42K Hold
6,750
– – ﹤0.01% 1102
2019
Q2 		$112K Hold
6,750
– – ﹤0.01% 1106
2019
Q1 		$113K Buy
6,750
+2,500
+59% +$36K ﹤0.01% 1101
2018
Q4 		$49K Buy
+4,250
New +$86K ﹤0.01% 1125

Other funds holding MRNS

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Gabelli Funds's MRNS Position: Q3 2020 in Review

Gabelli Funds sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2020, closing a stake of 6,750 shares — an estimated $69K sold.

Gabelli Funds first reported a position in MRNS in Q4 2018 and held it in 7 quarters. The position peaked at $113K in Q1 2019. 77 funds tracked by Wall St. Rank hold MRNS as of Q3 2020.

  • Gabelli Funds reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2020 after selling out during the quarter.
  • Gabelli Funds sold 6,750 Marinus Pharmaceuticals, Inc shares in Q3 2020, an estimated $69K.
  • Gabelli Funds first reported a position in Marinus Pharmaceuticals, Inc in Q4 2018 and held it in 7 quarters.
  • Gabelli Funds's Marinus Pharmaceuticals, Inc position peaked at $113K in Q1 2019.
  • 77 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2020.

Based on Gabelli Funds's 13F filing for Q3 2020, filed 6 Nov 2020.